Delivery Order SPE2DB25D3008-SPE2DB25FRCFG
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $12,674.74 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a completion date of October 1, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running...
- The Defense Logistics Agency awarded a $15.9K delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of TUKYSA 150 mg tablets (60-count units) with a firm fixed price structure and an ultimate completion date of September 3, 2025. This competitive award carries no set-aside designation and will be performed at the company's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for TUKYSA 150 mg tablets (120 count units) with a ceiling value of $15,756.32. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 14, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the vendor's demonstrated...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,756.32 firm fixed-price delivery order is for the supply of TUKYSA 150 MG Tablet, a pharmaceutical product. The contract has a completion date of May 28, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of TUKYSA 150 mg tablets (120 count) with a contract value of $12,697.69. This firm fixed-price delivery order, with an ultimate completion date of September 18, 2025, carries no set-aside designation and was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 18, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $47,268.96. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and carries no set-aside designation. The award is funded through the Defense Logistics Agency's Medical Supply Chain, which supports pharmaceutical...
- The Defense Logistics Agency awarded a $15,756.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 120 tablets of TUKYSA 150 mg, a prescription oncology medication. This delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, was competitively awarded without set-aside provisions. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $15,756.32 to AmerisourceBergen Drug Corp for TUKYSA 150 mg tablets (120-count units) under a firm fixed-price contract type. The award was made on September 26, 2025, with an ultimate completion date of October 20, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product TUKYSA 150 MG TABLET UU 120S. The award, valued at $12,273.50, has an ultimate completion date of April 22, 2024. Amerisourcebergen Drug Corp is the prime contractor and serves as a key supplier of pharmaceuticals, medical supplies, and related distribution services...
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $6,125.65 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TUKYSA 150 MG TABLET. The contract has a completion date of February 21, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp, as a prime contractor, has a long-standing relationship with DLA Troop Support Medical, providing a wide range of pharmaceutical...
- SPE2DB25D3008Indefinite Delivery Contract
- SPE2DB25D3008-SPE2DB25FRCFGDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 4, 2025, for the supply of TUKYSA 150 mg tablets (120-count units) valued at $15,756.32 under a firm fixed-price contract. This competitively awarded, non-set-aside delivery order is scheduled for completion by June 26, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle valued through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs through its extensive portfolio of delivery orders with the Defense Logistics Agency. The company's DLA contracts demonstrate consistent capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains, from specialty medications to vaccines and medical supplies, supporting military healthcare systems, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company maintains active engagement with the DLA's evolving Pharmaceutical Prime Vendor Global Program, reflecting its strategic importance to the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $15.8k | 6/4/25 |